Literature DB >> 8993724

Exercise-induced asthma: a practical guide to definitions, diagnosis, prevalence, and treatment.

J M Weiler1.   

Abstract

Exercise-induced asthma is defined as an intermittent narrowing of the airways, demonstrated by a decrease in some measure of flow, that the patient experiences as wheezing, chest tightness, coughing, and difficulty breathing that is triggered by exercise. Exercise will trigger asthma in most individuals who have chronic asthma, as well as in some who do not otherwise have asthma. Definitive diagnosis requires demonstration of a drop in flow rate, typically > or = 13-15% for forced expiratory volume in one second (FEV1) and > or = 15-20% for peak expiratory flow rate (PEFR), after exercise, associated with symptoms. Prevalence data indicate that this disorder is very common in those who participate in recreational sports as well as in highly competitive athletes, with at least 12-15% of unselected athletes having positive exercise challenges. Treatment of exercise induced asthma involves use of nonpharmacological measures (such as the use of the refractory period after exercise and prewarming air) as well as use of medications (beta-agonists, cromolyn, and nedocromil). With treatment, those who suffer from exercise-induced asthma may be able to participate and compete at the highest levels of performance.

Entities:  

Mesh:

Year:  1996        PMID: 8993724     DOI: 10.2500/108854196778606437

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  12 in total

1.  National athletic trainers' association position statement: preventing sudden death in sports.

Authors:  Douglas J Casa; Kevin M Guskiewicz; Scott A Anderson; Ronald W Courson; Jonathan F Heck; Carolyn C Jimenez; Brendon P McDermott; Michael G Miller; Rebecca L Stearns; Erik E Swartz; Katie M Walsh
Journal:  J Athl Train       Date:  2012 Jan-Feb       Impact factor: 2.860

Review 2.  Salmeterol. A review of its pharmacological properties and clinical efficacy in the management of children with asthma.

Authors:  J C Adkins; D McTavish
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

Review 3.  Zafirlukast. A review of its pharmacology and therapeutic potential in the management of asthma.

Authors:  J C Adkins; R N Brogden
Journal:  Drugs       Date:  1998-01       Impact factor: 9.546

Review 4.  Asthma and athletes: therapy to compete.

Authors:  John M Weiler; Christine Malloy
Journal:  Clin Rev Allergy Immunol       Date:  2005-10       Impact factor: 8.667

Review 5.  Prevalence and mechanisms of development of asthma and airway hyperresponsiveness in athletes.

Authors:  J B Langdeau; L P Boulet
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

6.  National Athletic Trainers' Association position statement: management of asthma in athletes.

Authors:  Michael G Miller; John M Weiler; Robert Baker; James Collins; Gilbert D'Alonzo
Journal:  J Athl Train       Date:  2005 Jul-Sep       Impact factor: 2.860

7.  Cromoglycate, reproterol, or both--what's best for exercise-induced asthma?

Authors:  T Küpper; K Goebbels; L N Kennes; N C Netzer
Journal:  Sleep Breath       Date:  2011-12-27       Impact factor: 2.816

8.  Applied kinesiology methods for a 10-year-old child with headaches, neck pain, asthma, and reading disabilities.

Authors:  Scott Cuthbert; Anthony Rosner
Journal:  J Chiropr Med       Date:  2010-09

Review 9.  Exercise-induced bronchospasm in children.

Authors:  Chris Randolph
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

Review 10.  Mast-cell stabilising agents to prevent exercise-induced bronchoconstriction.

Authors:  C H Spooner; G R Spooner; B H Rowe
Journal:  Cochrane Database Syst Rev       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.